Analysts Set IGM Biosciences, Inc. (NASDAQ:IGMS) Target Price at $5.50
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been given a consensus recommendation of “Reduce” by the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and nine have assigned a hold recommendation to the company. The average 1-year price objective […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been given a consensus recommendation of “Reduce” by the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and nine have assigned a hold recommendation to the company. The average 1-year price objective […]
